Bayer was ordered on [January 26] to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company’s Roundup weedkiller, the man’s attorneys said.
…
Bayer in a statement said it disagreed “with the jury’s adverse verdict that conflicts with the overwhelming weight of scientific evidence and worldwide regulatory and scientific assessments, and believe that we have strong arguments on appeal to get this verdict overturned and the unconstitutionally excessive damage award eliminated or reduced.”
Bayer added that some previous damages awards had been reduced by more than 90 percent.
Share this article
The verdict comes after five other recent wins late last year by plaintiffs suing Bayer over Roundup, though the company won the most recent such trial in December, as well as a string of earlier trials. In all, it has won 10 of the last 16 Roundup trials.
